Replies to post #252048 on Anavex Life Sciences Corp (AVXL)

[frrol]

He's clearly anxious to get 3-71 in the clinic. He put out a PR about doing a phase 1 with hints of it also being a 1b but not calling it that (strange) but not giving timeframes. He was saying "we're now moving forward on 3-71, just like we said we would, and when."

[Gernee20]

Sokol, no worries! You are an excellent poster thanks for your continued thoughts on the board.

I can’t remember but it was either 2018 or 2019 Missling first said he was going to move 3-71 into the clinic, by years end. The 3-71 ph1 was not on schedule. Not a big deal but those are the facts.

Question: if PDD does not meet primary endpoints but shows significant improvement in motor function, does our stock price get beaten down? Or do we rise being we will then run a ph3 for general PD with motor function as our primary endpoint? My opinion is we get attacked and manipulated like history has shown, as the FUD will point to our AD trial as a failure since PDD failed. Thoughts?